Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 9801 - 9808 of 12086 results
SHRM Online: NLRB Charges Against McDonald’s Put Focus on HR
February 10, 2015| Blog| Viewpoint
The Anthem Data Breach: The Fallout and What's Next
February 10, 2015| Blog| Viewpoint
DOJ Releases Electrifying New Guidance on Standard-Essential Patent Policy
February 10, 2015| Alert| Viewpoint
Sixth Circuit Finds Faulty Handbook Bars Employer from Challenging Employee’s Eligibility for FMLA Leave
February 9, 2015| Blog| Viewpoint
Puerto Rico’s Recovery Act Ruled Preempted: What Now?
February 8, 2015| Blog| Viewpoint
Trusted Traveler Programs: Expanded Resources for Today’s Business Traveler
February 5, 2015| Advisory| Viewpoint
President Obama Opens up Atlantic Coast for Oil and Gas Drilling, Restricts Alaskan Waters
February 5, 2015| Article| Viewpoint
No Representation Without Substantiation? What POM Wonderful v. FTC Means for Consumer Class Actions
February 5, 2015| Blog| Viewpoint
News & Press Releases
Mintz advised the creators of Morbid, one of the top-charting true crime podcasts, in a multi-year agreement to move to SiriusXM from Wondery. The deal gives SiriusXM exclusive advertising rights for the audio and video formats of the podcast.
Mintz Advises CVC DIF in Acquisition of SBA Communications’ Canadian Tower Infrastructure Platform
August 06, 2025
Mintz advised CVC DIF, the dedicated infrastructure investment strategy of global private markets manager CVC, in its agreement to acquire SBA Communications’ Canadian wireless tower business, one of Canada’s leading independent owners and operators of wireless communications towers. The transaction is expected to close in the fourth quarter of 2025, subject to customary closing conditions.
Mintz advised the underwriters in connection with a $69 million public offering by Larimar Therapeutics, Inc. of 21,562,500 shares of its common stock at a price to the public of $3.20 per share. The gross proceeds to Larimar from the offering were $69 million before deducting underwriting discounts and commissions and other offering expenses.
Events
Podcasts
Mintz On Air: Practical Policies — A Private Equity Non-Compete Primer
July 15, 2025| Podcast|
Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|